# Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer

> **NCT00897208** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 316 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** high performance liquid chromatography
- **OTHER:** laboratory biomarker analysis
- **OTHER:** mass spectrometry
- **OTHER:** medical chart review
- **PROCEDURE:** evaluation of cancer risk factors

## Key facts

- **NCT ID:** NCT00897208
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05-20
- **Primary completion:** 2010-06-17
- **Final completion:** 2015-06-30
- **Target enrollment:** 316 (ACTUAL)
- **Last updated:** 2018-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00897208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00897208, "Studying Biomarkers in Nipple Fluid, Urine, and Blood Samples From Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer and in Women at Risk of Developing Breast Cancer". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00897208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*